Data as of 11:50am ET
| -0.401 / -12.08%|
The 3 analysts offering 12-month price forecasts for Catalyst Pharmaceutical Partners Inc have a median target of 6.00, with a high estimate of 13.00 and a low estimate of 5.00. The median estimate represents a +105.55% increase from the last price of 2.92.
The current consensus among 3 polled investment analysts is to Buy stock in Catalyst Pharmaceutical Partners Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.